[{"AccountsPayableCurrent_0_Q1_USD":1115000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"PreferredStockSharesIssued_0_Q1_shares":1969797.0,"PreferredStockSharesOutstanding_0_Q1_shares":1969797.0,"PreferredStockValue_0_Q1_USD":null,"ShareBasedCompensation_1_Q1_USD":4846000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":816000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":632000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":4224000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":644413000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-35936000.0,"OperatingIncomeLoss_1_Q1_USD":-38005000.0,"InterestIncomeOther_1_Q1_USD":1870000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":-63000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":66651000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":109421000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":4846000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":4846000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":341859000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":19954000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":319000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":279000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":598000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":199000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":58647000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":125000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":33400000.0,"OperatingExpenses_1_Q1_USD":38005000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":415000.0,"Assets_0_Q1_USD":411457000.0,"AssetsCurrent_0_Q1_USD":409486000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":66651000.0,"CommonStockSharesIssued_0_Q1_shares":15429154.0,"CommonStockSharesOutstanding_0_Q1_shares":15429154.0,"CommonStockValue_0_Q1_USD":2000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-2.34,"GeneralAndAdministrativeExpense_1_Q1_USD":4605000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-175000.0,"Liabilities_0_Q1_USD":25982000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":411457000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"LiabilitiesCurrent_0_Q1_USD":25703000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":50460000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-30506000.0,"NetIncomeLoss_1_Q1_USD":-36135000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":314000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":976000.0,"ProfitLoss_1_Q1_USD":-36135000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1373000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-259355000.0,"StockholdersEquity_0_Q1_USD":385475000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":15429154.0,"AccruedLiabilitiesCurrent_0_Q1_USD":24269000.0,"LiabilitiesNoncurrent_0_Q1_USD":279000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":0.0,"Ticker":"MDGL","CIK":"1157601","name":"MADRIGAL PHARMACEUTICALS, INC.","OfficialName":"Madrigal Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1322434501.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]